BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Kerberos to Sell FDA Cleared Rinspiration Technology


5/7/2012 7:14:48 AM

PALO ALTO, Calif.--(BUSINESS WIRE)-- Co-Founders of Kerberos Proximal Solutions, Inc., announced today that, during the upcoming Paris Course on Revascularization (www.europcr.com), they plan to actively engage in discussions to put the company’s proprietary Rinspiration technology platform up for bid, seeking buyers with complementary portfolios and distribution channels.

The Rinspiration Thrombectomy System, developed by Kerberos Proximal Solutions, enables simultaneous rinsing and aspiration for the removal of acute thrombus in occluded arteries. "I have used the Kerberos System in the most challenging circumstances, both in the heart and the legs. I have found it to be one of the best thrombectomy devices on the market," commented Dr. Stefan Kiesz, interventional cardiologist and President of the San Antonio Endovascular & Heart Institute. Recognized by clinicians for its inherent efficiency and ease of use, the Rinspiration System experienced rapid early adoption for the treatment of patients suffering from acute myocardial infarction (AMI) and chronic limb ischemia (CLI).

With applications in both the coronary and peripheral space, the Kerberos system was sought after and ultimately acquired by FoxHollow Technologies in 2006. Due to an unexpected series of subsequent acquisitions by ev3 followed by Covidien, commercialization of the Rinspiration device became dormant, opening up the opportunity for Kerberos to regain rights to the technology.

The technology being offered for auction includes multiple published patents in the field of thrombectomy, proximal protection and physician specified vascular infusion along with multiple Design Dossiers and FDA cleared 510(k)s specific to the Rinspiration device.

John MacMahon, co-founder of Kerberos Proximal Solutions, commented "Management of acute thrombus remains a growing underserved clinical need. Our clinical data has clearly demonstrated the compelling benefits of the Rinspiration technology and we are excited to engage in conversations that enable reintroduction of the novel Rinspiration System to the market for the benefit of physicians seeking a better solution for the treatment of their patients."

The market for coronary and peripheral thrombectomy is estimated to exceed $300M in the US and represent an additional $600M opportunity outside of the US. Other players in the thrombectomy market include Medtronic [MDT], HotSpur Technologies, Medrad Interventional/ Possis [BAYN], Atrium Medical [STO:GETIB], and Spectranetics [SPNC].

About Kerberos Proximal Solutions

Kerberos Proximal Solutions was a privately-held medical device company based in Cupertino, Calif. Founded in 2001, Kerberos was dedicated to developing innovative solutions to treat vascular disease and pioneered the conception and development of the Rinspiration Thrombectomy System. Key investors in Kerberos included Research Corporation Technologies, Three Arch Partners, and Alta Partners.

Contact:

Kerberos Proximal Solutions, Inc.

John MacMahon, 603-264-7751

Co-Founder

JMacMahon@KPS-Rinspiration.com

or

Kerberos Legal Counsel

Morrison & Foerster

Kenneth Kuwayti, 650-813-5688

Partner

KKuwayti@mofo.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->